Merck (MRK) Change in Acquisitions & Divestments (2016 - 2025)
Merck (MRK) has disclosed Change in Acquisitions & Divestments for 17 consecutive years, with $46.0 million as the latest value for Q4 2025.
- On a quarterly basis, Change in Acquisitions & Divestments rose 557.14% to $46.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 345.09% increase, with the full-year FY2025 number at $1.7 billion, up 345.09% from a year prior.
- Change in Acquisitions & Divestments was $46.0 million for Q4 2025 at Merck, down from $575.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $704.0 million in Q3 2023 to a low of -$497.0 million in Q4 2021.
- A 5-year average of $206.4 million and a median of $260.0 million in 2024 define the central range for Change in Acquisitions & Divestments.
- Biggest YoY gain for Change in Acquisitions & Divestments was 49900.0% in 2023; the steepest drop was 2966.67% in 2023.
- Merck's Change in Acquisitions & Divestments stood at -$497.0 million in 2021, then soared by 102.41% to $12.0 million in 2022, then plummeted by 2966.67% to -$344.0 million in 2023, then soared by 102.03% to $7.0 million in 2024, then soared by 557.14% to $46.0 million in 2025.
- Per Business Quant, the three most recent readings for MRK's Change in Acquisitions & Divestments are $46.0 million (Q4 2025), $575.0 million (Q3 2025), and $601.0 million (Q2 2025).